These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6067456)

  • 1. Clinical studies of hemolytic complement and the 11S component.
    Hanauer LB; Christian CL
    Am J Med; 1967 Jun; 42(6):882-90. PubMed ID: 6067456
    [No Abstract]   [Full Text] [Related]  

  • 2. The complement system in necrotizing angiitis of the skin. Analysis of complement component activities in serum of patients with concomitant collagen-vascular diseases.
    Soter NA; Austen KF; Gigli I
    J Invest Dermatol; 1974 Aug; 63(2):219-26. PubMed ID: 4152325
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum levels of cartilage oligomeric matrix protein are elevated in rheumatoid arthritis, but not in inflammatory rheumatic diseases such as psoriatic arthritis, reactive arthritis, Raynaud's syndrome, scleroderma, systemic lupus erythematosus, vasculitis and Sjögren's syndrome.
    Skoumal M; Haberhauer G; Feyertag J; Kittl EM; Bauer K; Dunky A
    Arthritis Res Ther; 2004; 6(2):73-4. PubMed ID: 15059267
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunoconglutinin in various rheumatic diseases and certain diseases suspected of an autoimmune pathogenesis.
    Bienenstock J; Bloch KJ
    Arthritis Rheum; 1967 Jun; 10(3):187-98. PubMed ID: 6071719
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cryoglobulinemia in rheumatic diseases].
    Baranauskaĭte AA; Nasonov EL; Solov'ev SK
    Klin Med (Mosk); 1991 Jun; 69(6):23-32. PubMed ID: 1774903
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum pepsinogen I in rheumatic diseases. Reduced levels in Sjögren's syndrome.
    Maury CP; Räsänen V; Teppo AM; Helve T; Wegelius O
    Arthritis Rheum; 1982 Sep; 25(9):1059-63. PubMed ID: 6751336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hemorheologic disturbances and circulating immune complexes in patients with rheumatic diseases].
    Loskutova TT; Koreshkov GG; Nasonov EL; Zakharchenko VN; Larionov SM
    Ter Arkh; 1989; 61(5):51-5. PubMed ID: 2781490
    [No Abstract]   [Full Text] [Related]  

  • 8. Reflections in the assessment of secondary Sjogren's syndrome.
    Hernández-Molina G; Avila-Casado C; Sánchez-Guerrero J
    Rheumatology (Oxford); 2011 Aug; 50(8):1519-21. PubMed ID: 21672968
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum concentrations of cardiac troponin-I in patients with rheumatoid arthritis, systemic lupus erythematosus, primary Sjogren's syndrome and Graves' disease.
    Al-Awadhi AM; Olusi S; Hasan EA; Abdullah A
    Singapore Med J; 2007 Sep; 48(9):847-9. PubMed ID: 17728967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal structures in circulating lymphocytes from patients with systemic lupus erythematosus and related diseases.
    Grrimley PM; Decker JL; Michelitch HJ; Frantz MM
    Arthritis Rheum; 1973; 16(3):313-23. PubMed ID: 4708012
    [No Abstract]   [Full Text] [Related]  

  • 11. Sensitivity and specificity of anti-alpha-fodrin antibodies in primary Sjögren's syndrome.
    Szántó A; Csípo I; Zeher M
    J Rheumatol; 2005 Jan; 32(1):197; author reply 197-8. PubMed ID: 15630756
    [No Abstract]   [Full Text] [Related]  

  • 12. Autoantibodies binding to stathmin-4: new marker for polyneuropathy in primary Sjögren's syndrome.
    Duda S; Witte T; Stangel M; Adams J; Schmidt RE; Baerlecken NT
    Immunol Res; 2017 Dec; 65(6):1099-1102. PubMed ID: 29138979
    [No Abstract]   [Full Text] [Related]  

  • 13. [Autoimmune thrombopenic purpura revealing primary Sjögren's syndrome. 2 cases].
    Balquet MH; Hatron PY; Gosset D; Savinel P; Devulder B
    Rev Med Interne; 1989; 10(3):253-5. PubMed ID: 2669087
    [No Abstract]   [Full Text] [Related]  

  • 14. [Increased numbers of large granular lymphocytes in the peripheral blood in selected inflammatory rheumatic diseases].
    Rovenský J; Tóth J; Rauová L; Lukác J; Zlnay D
    Vnitr Lek; 1991 Jun; 37(6):572-7. PubMed ID: 1897139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance and practical value of determination of antistreptolysin titers].
    SEGA E; COLTELLI D
    Boll Ist Sieroter Milan; 1957; 36(1-2):80-9. PubMed ID: 13436607
    [No Abstract]   [Full Text] [Related]  

  • 16. C5 deficiency in a patient with primary Sjögren's syndrome.
    Schoonbrood TH; Hannema A; Fijen CA; Markusse HM; Swaak AJ
    J Rheumatol; 1995 Jul; 22(7):1389-90. PubMed ID: 7562780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [PROBABLE ROLE OF A HEREDITARY FACTOR IN THE DETERMINISM OF CERTAIN HEMOLYTIC ANEMIAS CAUSED BY AUTOANTIBODIES].
    DREYFUS B
    Nouv Rev Fr Hematol; 1964; 4():669-90. PubMed ID: 14201795
    [No Abstract]   [Full Text] [Related]  

  • 18. Low density neutrophils in patients with systemic lupus erythematosus, rheumatoid arthritis, and acute rheumatic fever.
    Hacbarth E; Kajdacsy-Balla A
    Arthritis Rheum; 1986 Nov; 29(11):1334-42. PubMed ID: 2430586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement and complement components in diseases of possible auto-immunological pathogenesis.
    JONSEN J; KASS E
    Acta Rheumatol Scand; 1961; 7():21-6. PubMed ID: 13790639
    [No Abstract]   [Full Text] [Related]  

  • 20. [Serum complement levels in systemic lupus erythematosus].
    Morita M; Nishishita S; Amano T; Ofuji T
    Arerugi; 1971 Mar; 20(3):159-68. PubMed ID: 4101817
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.